Low expression of rhodopsin kinase in pineal gland in Royal College of Surgeons rat. 2003

Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
Department of Ophthalmology, Hirosaki University School of Medicine, Hirosaki, Japan.

The Royal College of Surgeons (RCS) rat has been extensively characterized as a model for inherited retinal dystrophy such as retinitis pigmentosa. We have found that significantly low levels of expression of rhodopsin kinase (RK) and alphaA-crystallin may be involved in the pathogenesis of retinal degeneration in the RCS rat (Invest Ophthalmol Vis Sci. 1999,40:2788-2794). In the present study, we examined the expression of photoreceptor specific proteins in the pineal gland (PG) including rhodopsin kinase (RK), arrestin and recoverin, which are known to be commonly present in both photoreceptor and PG, in order to elucidate the pathological relationship between retina and PG during retinal degeneration. Among these proteins, RK expression was significantly decreased with advancing age (3-5 weeks old) in RCS rat. However, in contrast, arrestin expression in RCS PG was comparable with control PG and no expressions of recoverin and other G-protein coupled receptor kinases (GRKs 2, 5 and 6) were detected in RCS PG during 3-5 weeks of age. By administration of nilvadipine, an effective Ca2+ antagonist that was shown to preserve RCS retinal degeneration, RK expression was significantly enhanced.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D010870 Pineal Gland A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES. Epiphysis Cerebri,Pineal Body,Corpus Pineale,Gland, Pineal,Pineal Bodies,Pineal Glands
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D012162 Retinal Degeneration A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304) Degeneration, Retinal,Degenerations, Retinal,Retinal Degenerations
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal

Related Publications

Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
January 1990, Vision research,
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
September 2003, FEBS letters,
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
October 1984, Science (New York, N.Y.),
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
January 1989, Current eye research,
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
January 1992, Nippon Ganka Gakkai zasshi,
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
November 1866, Edinburgh medical journal,
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
November 1858, Edinburgh medical journal,
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
November 1865, Edinburgh medical journal,
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
July 1857, Edinburgh medical journal,
Yoshiko Takano, and Hiroshi Ohguro, and Ikuyo Ohguro, and Hitoshi Yamazaki, and Kazuhisa Mamiya, and Futoshi Ishikawa, and Mitsuru Nakazawa
November 1860, Edinburgh medical journal,
Copied contents to your clipboard!